AbbVie bets $10.9 billion on Apogee in next-generation immunology growth push
June 22 (Reuters) - AbbVie said on Monday it would buy biotech Apogee Therapeutics for $10.9 billion...
22nd June, 2026
June 22 (Reuters) - AbbVie said on Monday it would buy biotech Apogee Therapeutics for $10.9 billion...
22nd June, 2026
BERLIN, June 22 (Reuters) - Any plans by UniCredit to take Commerzbank private would be very difficu...
22nd June, 2026
June 22 (Reuters) - Australia's Accent Group said on Monday that an independent board committee comp...
22nd June, 2026
June 19 (Reuters) - UK-based private equity firm Pollen Street Capital on Friday said that it will a...
19th June, 2026
By Amy-Jo Crowley LONDON, June 18 (Reuters) - Ladbrokes-owner Entain has begun exploring options for...
18th June, 2026
By Anousha Sakoui LONDON, June 18 (Reuters) - Citi has hired William Mansfield as Head of M&A for th...
18th June, 2026
ROME, June 18 (Reuters) - The Italian government will take a neutral stance regarding merger and acq...
18th June, 2026
June 18 (Reuters) - French cosmetic maker L'Oreal will acquire a majority stake in India's Innovist...
18th June, 2026
By Vibhuti Sharma MUMBAI, June 18 (Reuters) - KKR is in advanced talks to buy a majority stake in th...
18th June, 2026
BRUSSELS, June 17 (Reuters) - A group of investors including Saudi Arabia's Public Investment Fund h...
17th June, 2026
By Elvira Pollina MILAN, June 17 (Reuters) - The new head of Italian yacht-maker Ferretti on Wednesd...
17th June, 2026
MILAN, June 17 (Reuters) - Leonardo Maria Del Vecchio is exploring private debt options to help fina...
17th June, 2026